Trial of Gilead's potential coronavirus treatment running ahead of schedule, says researcher |
Clinical News
eMediNexus Coverage from: 
Trial of Gilead's potential coronavirus treatment running ahead of schedule, says researcher

0 Read Comments                

Results for the U.S. government trial of Gilead Sciences Inc’s experimental coronavirus treatment may come out by mid-May, suggests the study’s lead investigator.

Lead researcher Dr. Andre Kalil told Reuters that the preliminary findings from the randomized trial of the antiviral drug remdesivir, started in February by the National Institute of Allergy and Infectious Diseases (NIAID), could come even sooner. Doctors at Houston Methodist Hospital told Reuters that since March 23, 41 mostly severely ill COVID-19 patients have been treated with the drug. None have died and half have been discharged. But more information is needed… (Reuters, April 24, 2020)

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now